Identification Protocol for Diploid Chimerism of mESCs
GUIDELINE
- When ESCs are injected into the host blastocyst cavity, they can integrate with the cells of the host inner cell mass and develop together into individuals, i.e., a chimera. ESCs originating from different animal strains have different genetic characteristics, and observation of these genetic characteristics can determine whether ESCs integrate, differentiate, and develop. Currently, the most common method is the observation of hair color in newborn individuals.
- There are two general ways to introduce ES cells into the embryo, namely the blastocyst lumen injection method and the polymerization method. The blastocyst cavity injection method is the classical method of chimeric animal production. It involves injecting ES cells into the blastocyst cavity by microinjection and culturing until the blastocyst cavity recovers for uterine transfer. There are two main polymerization methods, one is the "sandwich polymerization" method established by Wood et al. The second is the "sandwich polymerization" method established by Khillan et al, in which 8-16 cell embryos with the zona pellucida removed are polymerized on a monolayer of ES cells to produce chimeric animals.
METHODS
- Determine the source of ESCs and select the host mouse strain, Most ESCs are derived from 129 strain mice. 129 mice with wild gray fur should be selected from albino (e.g., BALB/c) and non-wild gray mice (e.g., C57BL/6), there are also ES cells derived from C57BL/6 mice, which should be selected from albino (e.g., BALB/c) and wild gray mice (e.g., 129 mice). The resulting chimeras should be fancy-colored rats, with coats that are white and wild gray or black and eyes with wild gray or black irises.
Creative Bioarray Relevant Recommendations
- Creative Bioarray supplies various options of embryonic stem cells from mice, such as XLC377, XLC349, XLC321, XLC243, XLC290, XLC224, XLC379, etc., to help our customers achieve efficient and accurate cell research. We have evaluated pluripotency through forming embryoid bodies, and you can trust our products.
- On the day of collection of 8-16 cell stage embryos, 20-30 small wells are made on a 6 cm petri dish. M16 droplets are placed on the wells and covered with paraffin oil and then equilibrated in the incubator.
- Firstly, the ES cells prepared for culture are washed 3 times with PBS.
- Add 0.05% trypsin to digest for 30 s and gently blow 2-3 times.
- Centrifuge at 4°C, 800 r/minutes for 5 minutes.
- Discard the supernatant, add ES culture medium and gently blow and then take 200 μL of mixture with a sparger, and select well-shaped ES cell clusters of 5-10, 10-15, 15-20, 20-25 under the microscope respectively.
- The ES cells are placed in the small wells of the pre-cultured perforated culture dishes.
- Next, the prepared embryos of the 8 to 16-cell stage are treated with an acidic Tyroid solution for a short time to remove the zona pellucida.
- Wash with PBS 4 to 5 times. The embryos are placed in a perforated culture dish with ES cell clusters. Each well of the perforated dish contains 1 ES cell cluster and 2 embryonic cells stripped of the zona pellucida.
- The cells are cultured in close contact with each other for 24 hours.
- After 24 hours of culture, embryos that have aggregated and are morphologically sound are selected for in-utero transfer. At the time of transfer, the mice with 2-5 days of pseudopregnancy are anesthetized with sodium barbital.
- Dorsal embryo transfer is performed, 8 to 10 embryos are transferred into each side of the uterus and raised individually after the procedure.
- The birth outcome of the chimeric mice is observed after 17 days.
NOTES
The acquisition of chimeric animals is a decisive step towards the ES cell pathway and can be used to screen for ES cells with germline transmission capability. With the completion of the Mouse Genome Project, more and more chimeric animal models will be prepared through the ES cell-mediated pathway. The polymerization method is simple and easy to perform and is an alternative method for preparing chimeric animals.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.
Resources
- FAQ
- Posters & Downloads
- Protocol
- Tools
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- Comparison of the MSCs from Different Sources
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- What Are Myeloid Cell Markers?
- How to Start Your Culture: Thawing Frozen Cells
- Techniques for Cell Separation
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Cell Cryopreservation Techniques and Practices
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- What Is Cell Proliferation and How to Analyze It?
- Direct vs. Indirect Cell-Based ELISA
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- STR Profiling—The ID Card of Cell Line
- How to Assess the Migratory and Invasive Capacity of Cells?
- Cryopreservation of Cells Step by Step
- What are PBMCs?
- Quantification of Cytokines
- T Cell Activation and Expansion
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Cell Culture Medium
- IL-12 Family Cytokines and Their Immune Functions
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Tips For Cell Cryopreservation
- How to Decide Between 2D and 3D Cell Cultures?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What are the Differences Between M1 and M2 Macrophages?
- Human Primary Cells: Definition, Assay, Applications
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- CHO Cell Line Development
- How to Eliminate Mycoplasma From Cell Cultures?
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Isolate PBMCs from Whole Blood?
- How to Handle Mycoplasma in Cell Culture?
- From Shake Flask to Bioreactor: 7 Scale-Up Risks
- How to Interpret ddPCR Results: Common Pitfalls and Troubleshooting
- ddPCR Assay Design for Gene Rearrangement Detection
- Why Your Cells Won't Detach? And How to Fix It?
- How to Identify and Troubleshoot Cell Morphology Changes
- Cell Clumping in Suspension Culture: Causes & Solutions
- Cell Culture Troubleshooting: Molecular Diagnostics & QC for Preclinical R&D
- Cell Density vs. Confluency: How to Optimize Cell Growth
- Cell Immortalization Step by Step
- Cell-Based High-Throughput Screening Techniques
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Optimization Strategies of Cell-Based Assays
- Adherent and Suspension Cell Culture
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- Role of Cell-Based Assays in Drug Discovery and Development
- Immunogenicity Testing: ELISA and MSD Assays
- What are White Blood Cells?
- Types of Cell Therapy for Cancer
- Overview of Cell Apoptosis Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- ddPCR vs qPCR vs NGS: Which Platform Fits Your Research?
- Cell Viability, Proliferation and Cytotoxicity Assays
- What Are CAR T Cells?
- Eosinophils vs. Basophils vs. Neutrophils
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Cultivated Meat: What to Know?
- 3D-Cell Model in Cell-Based Assay
- What Are the Pros and Cons of Adoptive Cell Therapy?
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Understanding Immunogenicity Assays: A Comprehensive Guide
-
Histology
- Fluorescent Nuclear Staining Dyes
- Troubleshooting in Fluorescent Staining
- Stains Used in Histology
- Immunohistochemistry Controls
- Overview of the FFPE Cell Pellet Product Lines
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- Cell Lysates: Composition, Properties, and Preparation
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Tips for Choosing the Right Protease Inhibitor
- Multiple Animal Tissue Arrays
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- Guides for Live Cell Imaging Dyes
- Mitochondrial Staining
- How to Choose the Right Positive and Negative Controls for IHC
- How to Optimize IHC Antibody Dilution: A Practical Guide
- Why Is My IHC Background Too High? A Step-by-Step Troubleshooting Guide
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- What You Must Know About Neuroscience IHC?
- Modern Histological Techniques
- How Immunohistochemistry Makes the Invisible Brain Visible?
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- Multiplexing Immunohistochemistry
- From Specimen to Slide: Core Methods in Histological Practice
- Serum vs. Plasma
- How to Begin with Multiplex Immunohistochemistry (mIHC)
-
Exosome
- Classification, Isolation Techniques and Characterization of Exosomes
- Emerging Technologies and Methodologies for Exosome Research
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Collection of Exosome Samples and Precautions
- Exosome Transfection for Altering Biomolecular Delivery
- How Important are Lipids in Exosome Composition and Biogenesis?
- Common Techniques for Exosome Nucleic Acid Extraction
- Exosome Size Measurement
- What are the Functions of Exosomal Proteins?
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- How to Apply Exosomes in Clinical?
- Techniques for Exosome Quantification
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Perform Targeted Modification of Exosomes?
- How to characterize exosomes?
- Summary of Approaches for Loading Cargo into Exosomes
- Exosome Antibodies
- The Role of Exosomes in Cancer
- How to Enhancement Exosome Production?
- Exosome Quality Control: How to Do It?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- What's the Potential of PELN in Disease Treatment?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
- How to Label Exosomes?
- Unraveling Biogenesis and Composition of Exosomes
-
ISH/FISH
- ISH probe labeling method
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- Multiple Approaches to Karyotyping
- Overview of Common FISH Techniques
- In Situ Hybridization Probes
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Guidelines for the Design of FISH Probes
- Small RNA Detection by ISH Methods
- Differences Between DNA and RNA Probes
- Overview of Oligo-FISH Technology
- How to Use FISH in Hematologic Neoplasms?
- FISH Tips and Troubleshooting
- CARD-FISH: Illuminating Microbial Diversity
- What are the Differences between FISH, aCGH, and NGS?
- Comparative Genomic Hybridization and Its Applications
- Telomere Length Measurement Methods
- Different Types of FISH Probes for Oncology Research
- RNAscope ISH Technology
- What Is the Use of FISH in Solid Tumors?
- What Types of Multicolor FISH Probe Sets Are Available?
- Reagents Used in FISH Experiments
- What are Single, Dual, and Multiplex ISH?
- Mapping of Transgenes by FISH
- How to Improve ISH Signal-to-Noise Ratio
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Toxicokinetics vs. Pharmacokinetics
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- What Are Metabolism-Mediated Drug-Drug Interactions?
- How to Improve Drug Plasma Stability?
- Traditional vs. Novel Drug Delivery Methods
- Key Factors Influencing Brain Distribution of Drugs
- Overview of In Vitro Permeability Assays
- The Rise of In Vitro Testing in Drug Development
- Predictive Modeling of Metabolic Drug Toxicity
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Key Considerations in Toxicokinetic
- Organ-on-a-Chip Systems for Drug Screening
- How to Design and Synthesize Antibody Drug Conjugates?
- What factors influence drug distribution?
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- How to Conduct a Bioavailability Assessment?
- Experimental Methods for Identifying Drug-Drug Interactions
- Physical and Chemical Properties of Drugs and Calculations
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Unraveling the Role of hERG Channels in Drug Safety
- Methods of Parallel Artificial Membrane Permeability Assays
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- What Are Compartment Models in Pharmacokinetics?
- Pharmacokinetics of Therapeutic Peptides
- How to Use iPSC-Derived Hepatocytes in Toxicity Studies
- In Vitro ADME vs In Vivo PK: Why Do Results Diverge?
- How Genotoxicity Testing Guides Safer Drug Development
- Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
- The Bioanalysis Masterclass: Labile Metabolites
- What Are Biomarkers in Drug Discovery?
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- Preclinical Workflow for Drug Toxicity Testing
- 2D vs 3D Cell Culture Models: Which Is Best for Drug Toxicity Testing?
- Bioanalysis Errors: How to Spot and Fix Them Early
- Troubleshooting Common Issues in Drug Toxicity Testing
- A Complete Guide to CYP Reaction Phenotyping in 2026
- In Vitro ADME vs In Vivo ADME
- Mastering the Noise: A Practical Guide to Minimizing Variability in Preclinical Studies
- Reaction Phenotyping vs. Metabolic Stability
- How to Interpret CYP Phenotyping Data
- When Should You Introduce ADME Tox Testing in Drug Development?
- Biomarkers vs. Functional Assays: Closing the Preclinical Gap
- How Are Biomarkers Validated in Drug Development?
- The Essentials of Quantitative Bioanalysis
- The 8 Costliest Mistakes in Preclinical CYP Phenotyping
- Why iPSC-derived Cells are Useful in Toxicology?
- Comparing Plasma Protein Binding Methods
- 6 Easy Steps to Get Your In Vitro ADME Done
- From Cells to Systems: Modern Approaches to Disease Modeling
- How Can You Optimize Drug Toxicity Assessment?
- Why Cardiotoxicity Matters in R&D?
- How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
- The 8 Types of Drug Toxicity Every Researcher Must Know
- What Are the Best Methods to Test Cardiotoxicity?
-
Disease Models
- Animal Models of Neurodegenerative Diseases
- Disease Models of Diabetes Mellitus
- Summary of Advantages and Limitations of Different Oncology Animal Models
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Why Use PDX Models for Cancer Research?
- Preclinical Models of Acute Liver Failure
- Scaling Organoid Screening: A Hands-On Guide for 3D Drug Discovery
- Bridging the Translational Gap: A Systematic Framework for Model Selection
- Advanced Organoid Culture: A Practical Optimization Guide
- Are You Choosing the Right Preclinical Model? 10 Key Questions
- How to Match Models to Drug Modalities: Small Molecules vs. Biologics
- How to Select the Right Preclinical Model for Drug Development
- Humanized Mouse Models: Core Technical Considerations
- Animal Models vs. NAMs: Understanding Modern Preclinical Research
- How to Select the Right Humanized Mouse Model for Immuno-Oncology
- Organoids vs Organ-on-Chip: Which is More Predictive?
- Implementing NAMs in Drug Development
- Organ-on-a-Chip: Is Your Microfluidic Setup Ready for Preclinical Trials?
- Why Oncology Organoids Fail? How to Build Models That Work
- Oncology Model Strategy: From Screening to Validation
- Static vs. Dynamic In Vitro Models
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter

